लोड हो रहा है...
Two‐stage design for phase I–II cancer clinical trials using continuous dose combinations of cytotoxic agents
We present a two-stage phase I/II design of a combination of two drugs in cancer clinical trials. The goal is to estimate safe dose combination regions with a desired level of efficacy. In stage I, conditional escalation with overdose control is used to allocate dose combinations to successive cohor...
में बचाया:
| में प्रकाशित: | J R Stat Soc Ser C Appl Stat |
|---|---|
| मुख्य लेखक: | |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368405/ https://ncbi.nlm.nih.gov/pubmed/30745708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/rssc.12294 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|